• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MANUFACTURING INC ARCHITECT LACTIC ACID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MANUFACTURING INC ARCHITECT LACTIC ACID Back to Search Results
Catalog Number 09D89-21
Device Problem Low Test Results (2458)
Patient Problem Misdiagnosis (2159)
Event Date 09/11/2016
Event Type  malfunction  
Manufacturer Narrative
Abbott laboratories identified negative interference from the drug n-acetyl cysteine (nac) with the architect lactic acid assay leading to falsely depressed lactic acid results.A product correction letter was issued to all current architect lactic acid customers.The letter informs the customer that patients undergoing treatment with n-acetyl cysteine (nac) may have falsely depressed lactic acid results.Architect lactic acid list number 09d89 is being discontinued.Customers who receive the final lots of list number 09d89 will be notified of the interference from nac via additional labeling (kit stuffer) contained within the reagent kit.
 
Event Description
The customer stated that they were made aware of a product recall from an abbott competitor regarding assay interference from n-acetyl cysteine (nac) with assays including glucose, lactic acid, uric acid and triglycerides.Upon doing research on the (b)(4), the customer found similar recalls from other competitors (beckman coulter, roche and siemens) over the past 18 months but nothing from abbott laboratories.The customer inquired as to whether abbott has any information regarding similar interference with architect assays.No discrepant architect patient results or impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT LACTIC ACID
Type of Device
LACTIC ACID
Manufacturer (Section D)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer (Section G)
ABBOTT MANUFACTURING INC
1921 hurd drive
irving TX 75038
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key6174867
MDR Text Key62467209
Report Number1628664-2016-00305
Device Sequence Number1
Product Code KHP
UDI-Device Identifier00380740121075
UDI-Public00380740121075
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Other Health Care Professional
Remedial Action Notification
Type of Report Initial
Report Date 12/14/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/15/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number09D89-21
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/09/2016
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Removal/Correction Number1628664-10/11/16-001-C
Patient Sequence Number1
Treatment
ARCHITECT C16000 SYSTEM; LIST 03L77-01, SERIAL (B)(4)
-
-